Abstract

Background: Keratinocyte growth factor (KGF) is a member of fibroblast growth factor (FGF) family which induces proliferation and differentiation in a wide variety of epithelial tissues. KGF plays an important role in protection, repair of various types of epithelial cells, and re-epithelialization of wounds. Therefore, in patients with hematologic malignancies receiving high doses of chemotherapy and radiotherapy, treatment with KGF decreases the incidence and duration of severe oral mucositis. Objectives: The aim of this study was to express the recombinant form of human keratinocyte growth factor in Escherichia coli. Materials and Methods: KGF gene was amplified by PCR and cloned into the expression vector pET28a(+). The recombinant vectors were transformed into E. coli BL21(DE3) as expression host and expression of the desired protein was induced by IPTG. The expression was evaluated at RNA and protein levels by reverse transcriptase PCR (RT-PCR) and SDS-PAGE analyses, respectively and the expressed protein was confirmed through western blotting. Results: Cloning was confirmed by PCR and restriction digestion. RT-PCR and SDS-PAGE represented expression of KGF in E. coli. The optimized expression was achieved 16 hours after induction with 0.3 mM IPTG at 37°C in luria broth (LB) containing kanamycin. The 18 kDa protein was confirmed by western blotting, using anti-His antibodies. Conclusions: The result of the present study indicated that E. coli expression system was suitable for overexpression of recombinant human KGF and the expressed protein can be considered as a homemade product.

Highlights

  • Keratinocyte growth factor (KGF) is a member of fibroblast growth factor (FGF) family which induces proliferation and differentiation in a wide variety of epithelial tissues

  • E. coli BL21(DE3) cells were transformed with recombinant vectors and grown at 37°C in luria broth (LB) medium containing appropriate antibiotic until the optical density at 600 nm of 0.4-0.6 was reached

  • Afterwards, 0.5 mM IPTG was added to the bacterial cultures to induce the expression of recombinant protein and they were incubated for 4 hours

Read more

Summary

Introduction

Keratinocyte growth factor (KGF) is a member of fibroblast growth factor (FGF) family which induces proliferation and differentiation in a wide variety of epithelial tissues. In patients with hematologic malignancies receiving high doses of chemotherapy and radiotherapy, treatment with KGF decreases the incidence and duration of severe oral mucositis. Objectives: The aim of this study was to express the recombinant form of human keratinocyte growth factor in Escherichia coli. Palifermin as a recombinant form of human KGF, due to its ability to cause proliferation of the oral mucosa and protect against mucosal injury, is a treatment option for high-risk patients for oral mucositis, ones with hematological malignancies receiving stem cell transplantation. Palifermin is the first FDA-approved drug which reduces the incidence and duration of severe oral mucositis by protecting those cells and stimulating the growth of new epithelial cells, to build up the mucosal barrier in patients with hematologic malignancies [2].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call